title: Timolol and aceclidine. A clinical study of interaction in the eye.
abstract: In the Netherlands timolol maleate, probably the drug of first choice in antiglaucoma therapy, is often combined with other intraocular pressure lowering drugs. The efficacy of most combinations have been discussed in the literature several times, except the one with aceclidine, a parasympathetic drug, that has a reasonable popularity in Western Europe. Unlike pilocarpine, aceclidine does not seem to give a clinically significant additional pressure lowering effect in timolol pre-treated eyes. The decrease in IOP in aceclidine pre-treated eyes after single dose timolol seems to be an effect of timolol alone. Our results suggest that co-administration of timolol and aceclidine is not a rational action in antiglaucomatous therapy.
authors.forename: B A
authors.initials: BA
authors.lastname: van der Pol
authors.forename: E
authors.initials: E
authors.lastname: Wattel
mesh_terms: D000368:Aged; D002986:Clinical Trials as Topic; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005260:Female; D005902:Glaucoma, Open-Angle / Q000188:drug therapy*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D011812:Quinuclidines / Q000627:therapeutic use*; D013999:Timolol / Q000627:therapeutic use*
chemical_list: D011812:Quinuclidines; D013999:Timolol